Evelo Biosciences Inc logo

Evelo Biosciences Inc

NEW
OTCPK:EVLO (USA)  
$ 0.00010 -0.000099 (-99%) 10:08 PM EST
At Loss
Volume:
0
Avg Vol (2M):
3.50K
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
3.50K

Business Description

Evelo Biosciences Inc logo
Evelo Biosciences Inc
NAICS : 325411 SIC : 2833
ISIN : US2997342025
Description
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
33.86
9-Day RSI
41.19
14-Day RSI
43.86
6-1 Month Momentum %
-80
12-1 Month Momentum %
-80

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2026-07-01 Est.)

EVLO's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:EVLO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Evelo Biosciences Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -14
Beta -2.4846
3-Year Sharpe Ratio 0.27
3-Year Sortino Ratio 0.67
Volatility % 81.73
14-Day RSI 43.86
14-Day ATR ($) 0.000017
20-Day SMA ($) 0.00013
12-1 Month Momentum % -80
52-Week Range ($) 0.0001 - 0.0006
Shares Outstanding (Mil) 18.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Evelo Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Evelo Biosciences Inc Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings results for 2026 2026-11-13 In 139 days
Second quarter earnings results for 2026 2026-08-20 In 54 days
Annual report for 2025 2026-07-01 In 4 days
First quarter earnings results for 2026 2026-07-01 In 4 days
General meeting for 2025 2026-06-30 In 3 days
0.05:1 Stock Split 2023-06-30 3.53 (-7.45%)
Show
Entries

Evelo Biosciences Inc Frequently Asked Questions

What is Evelo Biosciences Inc(EVLO)'s stock price today?
The current price of EVLO is $0.00. The 52 week high of EVLO is $0.00 and 52 week low is $0.00.
When is next earnings date of Evelo Biosciences Inc(EVLO)?
The next earnings date of Evelo Biosciences Inc(EVLO) is 2026-07-01 Est..
Does Evelo Biosciences Inc(EVLO) pay dividends? If so, how much?
Evelo Biosciences Inc(EVLO) does not pay dividend.

Guru Commentaries on OTCPK:EVLO

No articles.

Articles on Evelo Biosciences Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1